77 results
Page 2 of 4
424B3
exez 4gsm6rhbg
28 Aug 23
Prospectus supplement
9:10am
S-4/A
tjlo9y
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-10.47
1twqshr k4fk
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-10.48
2vfahlg2 bsuek0
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4/A
EX-10.46
hye9n4fzj b9iwwwe
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4
ldnnj5zzzcu8v
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
S-4
EX-10.44
ebk mnoxn6mc7aw
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
S-4
EX-10.45
uvwnbt4g
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
425
EX-10.5
u8abs vdvzw
29 Jun 23
Business combination disclosure
9:10am
425
EX-2.1
3xncgiouixk044gx
29 Jun 23
Business combination disclosure
9:10am
425
EX-10.2
sg87inws
29 Jun 23
Business combination disclosure
9:10am
425
EX-10.1
fwpmvixh qzi9iht3
29 Jun 23
Business combination disclosure
9:10am
8-K
EX-10.1
j9wda1hf
29 Jun 23
Immunome and Morphimmune Announce Definitive Merger Agreement
9:08am
8-K
EX-10.5
dpwo4yr p1y6lq4l52m
29 Jun 23
Immunome and Morphimmune Announce Definitive Merger Agreement
9:08am
8-K
EX-10.2
tcw580yzn
29 Jun 23
Immunome and Morphimmune Announce Definitive Merger Agreement
9:08am
8-K
EX-2.1
51tisgis9gec7d71
29 Jun 23
Immunome and Morphimmune Announce Definitive Merger Agreement
9:08am
PRE 14A
b6ytblzr pu8p1bu5wc
7 Apr 23
Preliminary proxy
6:29am
8-K
EX-99.2
3dlnb
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am